Design Therapeutics' GeneTAC platform is revolutionizing genetic disease treatment with small molecules and promising results ...
This article describes the foundations of omaveloxolone approval in Friedreich ataxia (FA) and discusses future directions in FA treatment. Friedreich ataxia (FA), a rare autosomal recessive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results